Journey Medical Corporation to Participate in October 2025 Investor Conferences

Core Insights - Journey Medical Corporation is a commercial-stage pharmaceutical company focused on FDA-approved prescription products for dermatological conditions [1][2] - The company will participate in two investor conferences in October 2025, indicating active engagement with the investment community [1][2] Event Details - The 4th Annual ROTH Healthcare Opportunities Conference will take place on October 9, 2025, in New York City, featuring 1x1 meetings [2] - The ThinkEquity Conference is scheduled for October 30, 2025, also in New York City, and will include presentations and 1x1 meetings [2] Company Overview - Journey Medical markets eight branded FDA-approved prescription drugs aimed at treating common skin conditions [2] - The company is based in Scottsdale, Arizona, and was founded by Fortress Biotech, Inc. [2] - Journey Medical's stock is registered under the Securities Exchange Act of 1934 and files periodic reports with the SEC [2]